Using specialized nanoparticles, MIT engineers have
developed a way to turn off specific genes in cells of the bone
marrow, which play an important role in producing blood cells.
These particles could be tailored to help treat heart disease or to
boost the yield of stem cells in patients who need stem cell
transplants, the researchers say.